1,2-dipalmitoylphosphatidylcholine has been researched along with Pancreatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, H; Deng, A; Fang, X; Gu, M; Kong, J; Liu, P | 1 |
| Arpicco, S; Beghelli, S; Costanzo, C; Dalla Pozza, E; Dando, I; Donadelli, M; Fattal, E; Lerda, C; Palmieri, M; Scarpa, A; Scupoli, MT; Zoratti, E | 1 |
2 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and Pancreatic Neoplasms
| Article | Year |
|---|---|
Nano-biotinylated liposome-based immunoassay for the ultrasensitive detection of protein biomarker in urine.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Biomarkers, Tumor; Biotinylation; Carcinoma, Pancreatic Ductal; Cholesterol; DNA; Humans; Immunoassay; Limit of Detection; Liposomes; Lithostathine; Nucleic Acid Amplification Techniques; Pancreatic Neoplasms; Reproducibility of Results | 2018 |
Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Cholesterol; Deoxycytidine; Flow Cytometry; Gemcitabine; Humans; Hyaluronan Receptors; Hyaluronic Acid; Liposomes; Mice; Mice, Nude; Microscopy, Confocal; Pancreatic Neoplasms; Phosphatidylethanolamines; Prodrugs; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |